Camino Menéndez

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring <i>MET</i> Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models

Lars D. Engstrom, Ruth Aranda, Matthew Lee et al. · Clinical Cancer Research · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +14

SPARC Expression Did Not Predict Efficacy of <i>nab</i> -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

Manuel Hidalgo, Carlos Plaza, Mónica Musteanu et al. · Clinical Cancer Research · 2015 · 131 citations · Full text

Medicine, Oncology, Pharmacology +12

Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR

Ana Ortega-Molina, Nerea Deleyto-Seldas, Joaquim Carreras et al. · Nature Metabolism · 2019 · 66 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells

Spas Dimitrov Markov, Javier Perales-Patón, Bruno Bockorny et al. · Molecular Cancer Therapeutics · 2020 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Transcriptional dissection of pancreatic tumors engrafted in mice

Raquel Martinez-Garcia, David Juan, Antonio Rausell et al. · Genome Medicine · 2014 · 45 citations · Full text

Life Sciences, Molecular Biology, Oncology +16